Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05113537
Title Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer (UPLIFT)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of California, San Francisco

prostate cancer


Abemaciclib + lutetium Lu 177 vipivotide tetraxetan

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.